Gainers
- Genesco Inc. (NYSE:GCO) rose 32.3% to close at $48.82 on Friday after the company reported upbeat Q3 earnings and issued strong FY20 EPS forecast.
- Big Lots, Inc. (NYSE:BIG) gained 31.6% to close at $25.21 after the company reported upbeat results for its third quarter.
- KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) gained 30.7% to close at $5.53 after OPEC and OPEC+ agreed to further oil production cuts.
- Wellesley Bancorp, Inc. (NASDAQ:WEBK) shares surged 30.3% to close at $42.10 on Friday. Cambridge Trust announced plans to acquire Wellesley Bank for $122 million.
- Cancer Genetics, Inc. (NASDAQ:CGIX) gained 26.9% to close at $6.99.
- Sierra Oncology Inc (NASDAQ:SRRA) surged 26.6% to close at $0.4850 after Oppenheimer initiated coverage on the company's stock with an Outperform rating and a $1.20 price target.
- DermTech, Inc. (NASDAQ:DMTK) gained 26.1% to close at $11.90.
- SAExploration Holdings, Inc. (NASDAQ:SAEX) surged 25% to close at $3.75.
- Kaleyra, Inc. (NYSE:KLR) gained 22.8% to close at $8.55.
- Domo, Inc. (NASDAQ:DOMO) rose 20% to close at $23.39 after the company reported Q3 EPS and sales results. The company also issued Q4 EPS and sales guidance above analyst estimates.
- Onconova Therapeutics Inc (NASDAQ:ONTX) gained 19.8% to close at $0.35 after the company announced it has entered into a collaboration agreement with Inceptua Medicines Access to make available intravenous rigosertib via pre-approval access program in selected countries.
- Epizyme, Inc. (NASDAQ:EPZM) gained 19.1% to close at $18.22 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised the price action from $12 to $22 per share.
- Johnson Outdoors Inc. (NASDAQ:JOUT) surged 19.1% to close at $78.17.
- Cerecor Inc. (NASDAQ:CERC) gained 18.7% to close at $4.00.
- EZCORP, Inc. (NASDAQ:EZPW) rose 18.4% to close at $6.19 following Q4 earnings.
- Montage Resources Corporation (NYSE:MR) climbed 17.2% to close at $6.21. ScotiaBank upgraded Montage Resources from Sector Perform to Sector Outperform.
- Zumiez Inc. (NASDAQ:ZUMZ) rose 16.1% to close at $35.47 after the company reported stronger-than-expected Q3 results and issued Q4 EPS guidance above analyst estimates.
- NF Energy Saving Corporation (NASDAQ:BIMI) gained 16% to close at $3.85.
- Stoke Therapeutics, Inc. (NASDAQ:STOK) jumped 15.8% to close at $28.98.
- Evolent Health, Inc. (NYSE:EVH) shares climbed 15.7% to close at $7.73 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) rose 15.1% to close at $4.87 on continued momentum after the company reported the topline Phase 1 data for its LX9211.
- Signet Jewelers Limited (NYSE:SIG) gained 15% to close at $20.58 on continued strength from Thursday's earnings report. Wells Fargo raised the price target to $16/share but said the company's core fundamental business remains 'pressured.'
- Tantech Holdings Ltd (NASDAQ:TANH) gained 14.6% to close at $2.35.
- Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) gained 13.5% to close at $22.36. Rocket Pharma reported that first patient has been treated in global registrational Phase 2 study of RP-L102 for fanconi anemia.
- BioLineRx Ltd. (NASDAQ:BLRX) rose 13.2% to close at $2.31.
- Nabors Industries Ltd. (NYSE:NBR) gained 12.9% to close at $2.36 after OPEC and OPEC+ agreed to further oil production cuts.
- LiveXLive Media, Inc. (NASDAQ:LIVX) rose 12.8% to close at $2.30.
- National Beverage Corp. (NASDAQ:FIZZ) climbed 12.1% to close at $54.06 following Q2 results.
- G1 Therapeutics, Inc. (NASDAQ:GTHX) gained 11.5% to close at $22.90.
- Immunomedics, Inc. (NASDAQ:IMMU) climbed 11.3% to close at $20.59 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
- Ulta Beauty, Inc. (NASDAQ:ULTA) rose 11.1% to close at $262.20 after the company reported better-than-expected Q3 EPS results. The company also narrowed its FY19 EPS guidance above analyst estimates.
- Whiting Petroleum Corporation (NYSE:WLL) surged 10.9% to close at $5.19 after OPEC and OPEC+ agreed to further oil production cuts.
- Alimera Sciences, Inc. (NASDAQ:ALIM) gained 10.8% to close at $7.52.
- The Chemours Company (NYSE:CC) climbed 10.8% to close at $16.68 on reports stating the House is said to be easing 'Forever chemical' wording.
- Prevail Therapeutics Inc. (NASDAQ:PRVL) rose 10.8% to close at $15.54.
- Nine Energy Service, Inc. (NYSE:NINE) surged 10.7% to close at $5.50.
- Calyxt, Inc. (NASDAQ:CLXT) rose 10.2% to close at $5.40.
- The Michaels Companies, Inc. (NASDAQ:MIK) gained 10% to close at $6.69.
- Kadmon Holdings, Inc. (NYSE:KDMN) shares rose 10% to close at $4.50.
- Avadel Pharmaceuticals plc (NASDAQ:AVDL) gained 9.4% to close at $6.30.
- Progyny, Inc. (NASDAQ:PGNY) gained 9.4% to close at $30.49.
- PolarityTE, Inc. (NASDAQ:PTE) surged 9.3% to close at $2.83.
- InMode Ltd. (NASDAQ:INMD) gained 8.8% to close at $47.42 in sympathy with the overall market amid a rally in US equities following strong November jobs data.
- Cloudera, Inc. (NYSE:CLDR) rose 8.7% to close at $10.88 after the company reported upbeat quarterly earnings.
- DocuSign, Inc. (NASDAQ:DOCU) rose 8.7% to close at $75.57 after reporting better-than-expected Q3 earnings results.
- Clovis Oncology, Inc. (NASDAQ:CLVS) gained 8.5% to close at $9.61 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
- Adverum Biotechnologies, Inc. (NASDAQ:ADVM) gained 8.4% to close at $11.43 in sympathy with the overall market after a rally in US equities following strong November jobs data.
- Hovnanian Enterprises, Inc. (NYSE:HOV) gained 7.9% to close at $26.94. Buckingham maintained Hovnanian with a Neutral and raised the price target from $24 to $27.
- Realogy Holdings Corp. (NYSE:RLGY) climbed 7.3% to close at $10.46 after moving back above the $10 level. Not currently seeing any company-specific news.
- Sage Therapeutics, Inc. (NASDAQ:SAGE) rose 7.1% to close at $64.46 after falling 59.67% on Thursday. SVB Leerink upgraded Sage Therapeutics from Underperform to Market Perform.
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) rose 6.4% to close at $10.61. Goldman Sachs upgraded Kiniksa Pharmaceuticals from Neutral to Buy and raised the price target from $16 to $18.
- Puma Biotechnology, Inc. (NASDAQ:PBYI) rose 5.9% to close at $7.88. H.C. Wainwright initiated coverage on Puma Biotechnology with a Buy rating and a $15 price target.
- Harpoon Therapeutics, Inc. (NASDAQ:HARP) climbed 5.6% to close at $18.93.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- Correvio Pharma Corp. (NASDAQ:CORV) shares tumbled 39.8% to close at $1.30 on Friday.
- Axcella Health Inc. (NASDAQ:AXLA) shares fell 20% to close at $3.59.
- Cortexyme, Inc. (NASDAQ:CRTX) dropped 17.5% to close at $28.31.
- Liquid Media Group Ltd. (NASDAQ:YVR) dipped 17.4% to close at $2.43.
- Kaleido BioSciences, Inc. (NASDAQ:KLDO) shares declined 16.5% to close at $5.36.
- Cabaletta Bio, Inc. (NASDAQ:CABA) dropped 16% to close at $10.21.
- Electromed, Inc. (NYSE:ELMD) dipped 14.8% to close at $8.47.
- Yext, Inc. (NYSE:YEXT) fell 14.1% to close at $14.26 after the company reported worse-than-expected Q3 EPS results and issued weak forecast.
- PagerDuty, Inc. (NYSE:PD) shares fell 12.7% to close at $21.81 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 and FY20 EPS guidance below analyst estimates.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) dropped 10.5% to close at $5.13.
- Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) dipped 10.3% to close at $107.48. Intercept announced publication of results from the interim analysis of the Phase 3 REGENERATE study of OCA for the treatment of fibrosis due to NASH in The Lancet.
- Zoom Video Communications, Inc. (NASDAQ:ZM) fell 10% to close at $62.74 after the company reported Q3 earnings results. The company also issued Q4 and FY20 guidance.
- China Automotive Systems, Inc. (NASDAQ:CAAS) fell 9.7% to close at $3.52.
- Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) shares dropped 9.4% to close at $24.24.
- IDT Corporation (NYSE:IDT) fell 9.3% to close at $6.80 following Q1 results.
- Anavex Life Sciences Corp. (NASDAQ:AVXL) dropped 8.9% to close at $2.65.
- IMAC Holdings, Inc. (NASDAQ:IMAC) fell 8% to close at $1.84.
- Oyster Point Pharma, Inc. (NASDAQ:OYST) shares fell 7.9% to close at $16.99.
- Guidewire Software Inc (NYSE:GWRE) fell 7.2% to close at $110.77 after the company issued Q2 sales guidance below analyst estimates.
- Proteostasis Therapeutics, Inc. (NASDAQ:PTI) declined 6.3% to close at $3.55.
- ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell 5.2% to close at $2.36 on continued downward momentum after the company priced a 5.2 million ADS offering at $2.50 per ADS.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.